aluates Reports

$ 0.0

Automative

Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-32H18465

BUY CHAPTERS

Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2024

Code: QYRE-Auto-32H18465

Report

November 2024

Pages:70

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Daiichi Sankyo

Menarini Group

Simcere Pharmaceutical

Lunan Pharmaceutical Group

Edoxaban Tosilate Tablets and Generic Drugs Market Size

The global Edoxaban Tosilate Tablets and Generic Drugs market was valued at US$ 1741 million in 2023 and is anticipated to reach US$ 2469 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Edoxaban Tosilate Tablets and Generic Drugs Market

Edoxaban is a member of the Novel Oral Anti-Coagulants (NOACs) class of drugs, and is a rapidly acting, oral, selective factor Xa inhibitor. By inhibiting factor Xa, a key protein in the coagulation cascade, edoxaban prevents the stepwise amplification of protein factors needed to form blood clots. It is indicated to reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF) and for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5-10 days of initial therapy with a parenteral anticoagulant. Traditionally, warfarin, a vitamin K antagonist, was used for stroke prevention in these individuals but effective use of this drug is limited by it's delayed onset, narrow therapeutic window, need for regular monitoring and INR testing, and numerous drug-drug and drug-food interactions. This has prompted enthusiasm for newer agents such as dabigatran, apixaban, and rivaroxaban for effective clot prevention. In addition to once daily dosing, the benefits over warfarin also include significant reductions in hemorrhagic stroke and GI bleeding, and improved compliance, which is beneficial as many patients will be on lifelong therapy.

North American market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Edoxaban Tosilate Tablets and Generic Drugs include Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Edoxaban Tosilate Tablets and Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edoxaban Tosilate Tablets and Generic Drugs.

The Edoxaban Tosilate Tablets and Generic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Edoxaban Tosilate Tablets and Generic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Edoxaban Tosilate Tablets and Generic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Edoxaban Tosilate Tablets and Generic Drugs Market Report

Report Metric	Details
Report Name	Edoxaban Tosilate Tablets and Generic Drugs Market
Accounted market size in 2023	US$ 1741 million
Forecasted market size in 2030	US$ 2469 million
CAGR	4.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	30 mg 60 mg Other
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Edoxaban Tosilate Tablets and Generic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Edoxaban Tosilate Tablets and Generic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Edoxaban Tosilate Tablets and Generic Drugs Market growing?

Ans: The Edoxaban Tosilate Tablets and Generic Drugs Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Edoxaban Tosilate Tablets and Generic Drugs Market size in 2030?

Ans: The Edoxaban Tosilate Tablets and Generic Drugs Market size in 2030 will be US$ 2469 million.

Who are the main players in the Edoxaban Tosilate Tablets and Generic Drugs Market report?

Ans: The main players in the Edoxaban Tosilate Tablets and Generic Drugs Market are Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group

What are the Application segmentation covered in the Edoxaban Tosilate Tablets and Generic Drugs Market report?

Ans: The Applications covered in the Edoxaban Tosilate Tablets and Generic Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Edoxaban Tosilate Tablets and Generic Drugs Market report?

Ans: The Types covered in the Edoxaban Tosilate Tablets and Generic Drugs Market report are 30 mg, 60 mg, Other

Recommended Reports

Anticoagulant Drugs

Stroke & Vascular

NOACs & Generics

1 Edoxaban Tosilate Tablets and Generic Drugs Market Overview

1.1 Product Definition

1.2 Edoxaban Tosilate Tablets and Generic Drugs by Type

1.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Value Comparison by Type (2024-2030)

1.2.2 30 mg

1.2.3 60 mg

1.2.4 Other

1.3 Edoxaban Tosilate Tablets and Generic Drugs by Application

1.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Estimates and Forecasts

1.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue 2019-2030

1.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales 2019-2030

1.4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Edoxaban Tosilate Tablets and Generic Drugs Market Competition by Manufacturers

2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Edoxaban Tosilate Tablets and Generic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Product Type & Application

2.7 Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Date of Enter into This Industry

2.8 Global Edoxaban Tosilate Tablets and Generic Drugs Market Competitive Situation and Trends

2.8.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Edoxaban Tosilate Tablets and Generic Drugs Players Market Share by Revenue

2.8.3 Global Edoxaban Tosilate Tablets and Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Edoxaban Tosilate Tablets and Generic Drugs Market Scenario by Region

3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2019-2030

3.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2019-2024

3.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2025-2030

3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2019-2030

3.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2019-2024

3.3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2025-2030

3.4 North America Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Country

3.4.1 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2019-2030)

3.4.3 North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Country

3.5.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2019-2030)

3.5.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2019-2030)

3.6.3 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Country

3.7.1 Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2019-2030)

3.7.3 Latin America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2019-2030)

4.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2019-2024)

4.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2025-2030)

4.1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2019-2030)

4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2019-2030)

4.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2019-2024)

4.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2025-2030)

4.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2019-2030)

5.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2019-2024)

5.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2025-2030)

5.1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2019-2030)

5.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2019-2030)

5.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2019-2024)

5.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2025-2030)

5.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Daiichi Sankyo

6.1.1 Daiichi Sankyo Company Information

6.1.2 Daiichi Sankyo Description and Business Overview

6.1.3 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio

6.1.5 Daiichi Sankyo Recent Developments/Updates

6.2 Menarini Group

6.2.1 Menarini Group Company Information

6.2.2 Menarini Group Description and Business Overview

6.2.3 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio

6.2.5 Menarini Group Recent Developments/Updates

6.3 Simcere Pharmaceutical

6.3.1 Simcere Pharmaceutical Company Information

6.3.2 Simcere Pharmaceutical Description and Business Overview

6.3.3 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio

6.3.5 Simcere Pharmaceutical Recent Developments/Updates

6.4 Lunan Pharmaceutical Group

6.4.1 Lunan Pharmaceutical Group Company Information

6.4.2 Lunan Pharmaceutical Group Description and Business Overview

6.4.3 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio

6.4.5 Lunan Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Edoxaban Tosilate Tablets and Generic Drugs Industry Chain Analysis

7.2 Edoxaban Tosilate Tablets and Generic Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Edoxaban Tosilate Tablets and Generic Drugs Production Mode & Process

7.4 Edoxaban Tosilate Tablets and Generic Drugs Sales and Marketing

7.4.1 Edoxaban Tosilate Tablets and Generic Drugs Sales Channels

7.4.2 Edoxaban Tosilate Tablets and Generic Drugs Distributors

7.5 Edoxaban Tosilate Tablets and Generic Drugs Customers

8 Edoxaban Tosilate Tablets and Generic Drugs Market Dynamics

8.1 Edoxaban Tosilate Tablets and Generic Drugs Industry Trends

8.2 Edoxaban Tosilate Tablets and Generic Drugs Market Drivers

8.3 Edoxaban Tosilate Tablets and Generic Drugs Market Challenges

8.4 Edoxaban Tosilate Tablets and Generic Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Daiichi Sankyo

Menarini Group

Simcere Pharmaceutical

Lunan Pharmaceutical Group

List of Tables

Table 1. Global Edoxaban Tosilate Tablets and Generic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Edoxaban Tosilate Tablets and Generic Drugs Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Edoxaban Tosilate Tablets and Generic Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Edoxaban Tosilate Tablets and Generic Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Edoxaban Tosilate Tablets and Generic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Edoxaban Tosilate Tablets and Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edoxaban Tosilate Tablets and Generic Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Daiichi Sankyo Company Information

Table 71. Daiichi Sankyo Description and Business Overview

Table 72. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product

Table 74. Daiichi Sankyo Recent Developments/Updates

Table 75. Menarini Group Company Information

Table 76. Menarini Group Description and Business Overview

Table 77. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product

Table 79. Menarini Group Recent Developments/Updates

Table 80. Simcere Pharmaceutical Company Information

Table 81. Simcere Pharmaceutical Description and Business Overview

Table 82. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product

Table 84. Simcere Pharmaceutical Recent Developments/Updates

Table 85. Lunan Pharmaceutical Group Company Information

Table 86. Lunan Pharmaceutical Group Description and Business Overview

Table 87. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product

Table 89. Lunan Pharmaceutical Group Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Edoxaban Tosilate Tablets and Generic Drugs Distributors List

Table 93. Edoxaban Tosilate Tablets and Generic Drugs Customers List

Table 94. Edoxaban Tosilate Tablets and Generic Drugs Market Trends

Table 95. Edoxaban Tosilate Tablets and Generic Drugs Market Drivers

Table 96. Edoxaban Tosilate Tablets and Generic Drugs Market Challenges

Table 97. Edoxaban Tosilate Tablets and Generic Drugs Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Edoxaban Tosilate Tablets and Generic Drugs

Figure 2. Global Edoxaban Tosilate Tablets and Generic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Edoxaban Tosilate Tablets and Generic Drugs Market Share by Type: 2023 & 2030

Figure 4. 30 mg Product Picture

Figure 5. 60 mg Product Picture

Figure 6. Other Product Picture

Figure 7. Global Edoxaban Tosilate Tablets and Generic Drugs Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Edoxaban Tosilate Tablets and Generic Drugs Market Share by Application: 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size (2019-2030) & (US$ Million)

Figure 14. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (2019-2030) & (K Units)

Figure 15. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price (US$/Unit) & (2019-2030)

Figure 16. Edoxaban Tosilate Tablets and Generic Drugs Report Years Considered

Figure 17. Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Manufacturers in 2023

Figure 18. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Edoxaban Tosilate Tablets and Generic Drugs Players: Market Share by Revenue in Edoxaban Tosilate Tablets and Generic Drugs in 2023

Figure 20. Edoxaban Tosilate Tablets and Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2019-2030)

Figure 23. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Country (2019-2030)

Figure 24. United States Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2019-2030)

Figure 27. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Country (2019-2030)

Figure 28. Germany Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2019-2030)

Figure 35. China Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2019-2030)

Figure 43. Mexico Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Edoxaban Tosilate Tablets and Generic Drugs by Type (2019-2030)

Figure 53. Global Revenue Market Share of Edoxaban Tosilate Tablets and Generic Drugs by Type (2019-2030)

Figure 54. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Edoxaban Tosilate Tablets and Generic Drugs by Application (2019-2030)

Figure 56. Global Revenue Market Share of Edoxaban Tosilate Tablets and Generic Drugs by Application (2019-2030)

Figure 57. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Application (2019-2030)

Figure 58. Edoxaban Tosilate Tablets and Generic Drugs Value Chain

Figure 59. Edoxaban Tosilate Tablets and Generic Drugs Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral Factor Xa Inhibitors Market Research Report 2024

Global Edoxaban API Market Research Report 2024

Global Direct Oral Anticoagulants DOACs Market Research Report 2024

Global Edoxaban Reagent Market Research Report 2024

Global Rivaroxaban Drugs Market Research Report 2024

Global Factor Xa Inhibitors Market Research Report 2024

Rivaroxaban API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global FXa Inhibitor Market Research Report 2025

Global Rivaroxaban Tablets Market Research Report 2024

Global Dabigatran Etexilate Drugs Market Research Report 2024

Global Rivaroxaban Market Insights Forecast to 2030

Global Dabigatran Etexilate Mesylate Market Research Report 2024

Global Dabigatran Etexilate Capsules Market Research Report 2024

Global Oral Anticoagulants Market Research Report 2024

Global Dabigatran Market Insights Forecast to 2030

Global Direct Oral Anticoagulant Market Insights Forecast to 2030

Global Enoxaparin Sodium Market Research Report 2024

Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2030

Global Warfarin Sodium Tablets Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions